Investors who purchased ASP Isotopes Inc. (NASDAQ: ASPI) common stock between September 26, 2024 and November 26, 2024 may qualify to claim a share of the $9.35 million ASP Isotopes securities class action settlement, estimated at about $0.38 per affected share before fees. Claims close December 2, 2026, and the final approval hearing is set for December 15, 2026.
Free settlement alerts
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
No. Only purchases of ASP Isotopes publicly traded common stock made from September 26, 2024 through November 26, 2024 are covered. Shares already held before the class period began are not eligible, although the claim form may ask about those holdings so the administrator can match purchases against sales.
The roughly $0.38 figure is an average across all affected shares before fees and expenses. Each authorized claimant is paid a pro rata share of the net settlement fund based on their own Recognized Loss under the plan of allocation, compared with the total Recognized Losses of everyone who files a valid claim. The final amount depends on when shares were bought and sold and on how many investors file.
The plan of allocation does not issue a payment to an authorized claimant whose share of the net settlement fund comes to less than $10. Small positions or short holding periods can fall below that line even when the claim itself is valid.
No. The claim form does not ask for a notice ID or claim number from a mailed notice. It does require a valid email address and documentation of the ASP Isotopes transactions being claimed, such as brokerage statements or trade confirmations.
A class member who neither files a claim nor asks to be excluded by November 20, 2026 receives no payment but is still bound by the settlement if the court approves it, and gives up the right to sue the defendants separately over the claims it releases.